Individualized immune monitoring of cardiac transplant recipients by noninvasive longitudinal cellular immunity tests

Transplantation

Volumn 89, Issue 8, 2010, Pages 968-976

  Israeli, Moshe ^a,c   Ben Gal, Tuvia ^a,b   Yaari, Vicktoria ^a,b   Valdman, Andrei ^a,b   Matz, Israel ^a,b   Medalion, Benjamin ^a,b   Battler, Alexander ^a,b   Sredni, Benjamin ^c   Kristt, Don ^a,b   Klein, Tirza ^a,b  

^a Rabin Medical Center   (Ireland)

^b TEL AVIV UNIVERSITY   (Israel)

^c BAR ILAN UNIVERSITY   (Israel)

Author keywords

Heart transplantation; Immune monitoring; Immunosuppression; Posttransplant

Indexed keywords

CALCINEURIN INHIBITOR; CYCLOSPORIN A; EVEROLIMUS; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; DRUG BLOOD LEVEL; FEMALE; GRAFT RECIPIENT; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HUMAN; IMMUKNOW ASSAY; IMMUNOASSAY; MALE; PRIORITY JOURNAL; UNSPECIFIED SIDE EFFECT;

EID: 77951280166     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181cbabe6     Document Type: Article

References (16)

1. Sottong PR, Rosebrock JA, Britz JA, et al. Measurement of T-lymphocyte responses in whole-blood cultures using newlysynthesized DNA and ATP. Clin Diagn Lab Immunol 2000; 7: 307.
2. Kowalski R, Post D, Schneider MC, et al. Immune cell function testing: An adjunct to therapeutic drug monitoring in transplant patient management. Clin Transplant 2003; 17: 77.
3. Cabrera R, Ararat M, Soldevila-Pico C, et al. Using an immune functional assay to differentiate acute cellular rejection from recurrent hepatitis C in liver transplant patients. Liver Transpl 2009; 15: 216.
4. Kowalski RJ, Post DR, Mannon RB, et al. Assessing relative risks of infection and rejection: A meta-analysis using an immune function assay. Transplantation 2006; 82: 663.
5. Patel J, Kobashigawa JA. Minimization of immunosuppression: Transplant immunology. Transpl Immunol 2008; 20: 48.
6. Sampson V, Dunn S, Rymeskia B, et al. Failure of immunosuppressive drug levels to predict T-cell reactivity in pediatric transplant patients. J Pediatr Surg 2008; 43: 1134.
7. Sawitzki B, Pascher A, Babel N, et al. Can we use biomarkers and functional assays to implement personalized therapies in transplantation? Transplantation 2009; 87: 1595.
8. Hooper E, Hawkins DM, Kowalski RJ, et al. Establishing pediatric immune response zones using the Cylex ImmuKnow assay. Clin Transplant 2005; 19: 834.
9. Israeli M, Yussim A, Mor E, et al. Preceeding the rejection:In search for a comprehensive post-transplant immune monitoring platform. Transpl Immunol 2007; 18: 7.
10. Israeli M, Klein T, Sredni B, et al. ImmuKnow: A new parameter in immune monitoring of pediatric liver transplantation recipients. Liver Transpl2008; 14: 893.
11. + cells in kidney transplant patients with and without infection. Clin Transpl2008; 22: 55.
12. Thai N, Blisard D, Tom K, et al. Pancreas transplantation under ale-mtuzumab (Campath-1H) and tacrolimus: Correlation between low T-cell responses and infection. Transplantation 2006; 82: 1649.
13. Bhorade S, Janata K, Vigneswaran W, et al. Cylex ImmuKnow assay levels are lower in lung transplant recipients with infection. J Heart Lung Transplant 2008; 27: 990.
14. Gupta S, Mitchell J, Markham D, et al. Utility of the Cylex assay in cardiac transplant recipients. J Heart Lung Transplant 2008; 27: 817.
15. Gautam A, Morrissey PE, Brem AS, et al. Use of an immune function assay to monitor immunosuppression for treatment of post-transplant lymphoproliferative disorder. Pediatr Transplant 2006; 10: 613.
16. Rossano JW, Denfield SW, Kim JJ, et al. Assessment of the Cylex ImmuKnow cell function assay in pediatric heart transplant patients. J Heart Lung Transplant 2009; 28: 26.